In our previous studies, we constructed a recombinant oncolytic adenovirus Ad-UPII-E1A that targeted bladder cancer cells for E1A expression under the control of the UPII promotor [16, 17]. The gene discussed is UPK2; the disease is urinary bladder cancer.